Cover Image, Volume 61, Issue 7.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. i, doi. 10.1002/mc.23439
- By:
- Publication type:
- Article
Works matching IS 08991987 AND DT 2022 AND VI 61 AND IP 7
Results: 11
1
2
Quercetin attenuates the proliferation of arsenic‐related lung cancer cells via a caspase‐dependent DNA damage signaling.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 655, doi. 10.1002/mc.23408
- By:
- Publication type:
- Article
3
SIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 702, doi. 10.1002/mc.23412
- By:
- Publication type:
- Article
4
Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 690, doi. 10.1002/mc.23411
- By:
- Publication type:
- Article
5
Independent effects of Src kinase and podoplanin on anchorage independent cell growth and migration.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 677, doi. 10.1002/mc.23410
- By:
- Publication type:
- Article
6
Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell‐like properties and phosphoinositide 3‐kinase inhibitor insensitivity.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 664, doi. 10.1002/mc.23409
- By:
- Publication type:
- Article
7
Characterization of stage‐specific tumor progression in TMPRSS2‐ERG (fusion)‐driven and non‐fusion‐driven prostate cancer in GEM models.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 717, doi. 10.1002/mc.23413
- By:
- Publication type:
- Article
8
Delineating functional mechanisms of the p53/p63/p73 family of transcription factors through identification of protein–protein interactions using interface mimicry.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 629, doi. 10.1002/mc.23405
- By:
- Publication type:
- Article
9
Genetic variants in DDO and PEX5L in peroxisome‐related pathways predict non‐small cell lung cancer survival.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 619, doi. 10.1002/mc.23400
- By:
- Publication type:
- Article
10
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 615, doi. 10.1002/mc.23317
- Publication type:
- Article
11
Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial–mesenchymal transition and stem cell markers.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 7, p. 643, doi. 10.1002/mc.23406
- By:
- Publication type:
- Article